References
- Stempel D A, Mellon M. Management of acute severe asthma. Pediatr Clin North Am 1984; 31: 879
- National Asthma Education Program Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health Publication, No 91–3042, U.S. Department of Health and Human Services. August, 1991; 104–115
- Zeiger R S. Special considerations in the approach to asthma in infancy and early childhood. J Asthma 1983; 20: 341
- Helfaer M A, Nichols D G, Chantarojanasiri T, Rogers M C. Lower airway disease: Bronchiolitis and asthma. Textbook of Pediatric Intensive Care, M A Rogers. Williams & Wilkins, Baltimore 1992; Vol 1: 263–295
- Wood D W, Downes J J, Leeks H I. A clinical scoring system for the diagnosis of respiratory failure. Am J Dis Child 1972; 123: 227
- Moler F W, Hurwitz Me, Custer J R. Improvement in clinical asthma score and PaCO2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol 1988; 81: 1101
- Nonparametric Statistics for the Behavioral Sciences, McGraw-Hill Series in Psychology, C T Morgan, S Siegel. McGraw-Hill, New York 1956; 63–67, Consulting Editor
- Schuh S, Parkin P, Rajan A, Canny G, Healy R, Rieder M, Tan Y, Levison H, Soldin S. High-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics 1989; 83: 513
- Schuh S, Reider M, Canny G, Fender E, Forbes T, Tan Y, Bailey D, Levison H. Nebulized albuterol in acute childhood asthma: Comparison of two doses. Pediatrics 1990; 86: 509
- Robertson C F, Smith F, Beck R, Levison H. Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatrics 1985; 106: 672
- Portnoy J, Aggarwal J. Continuous terbutaline nebulization for the treatment of severe exacerbations of asthma in children. Ann Allergy 1988; 60: 368
- Kelly H W, McWilliams B, Katz R, Murphy S. Safety of frequent high dose nebulized terbutaline in children with acute severe asthma. Ann Allergy 1990; 64: 229
- Moore J, Driscoll D, Kaufman C, Rolson A. Intravenous terbutaline control of severe pediatric asthma. Am Rev Respir Dis 1992; 145: A740, (abstract)
- Macguire J F, O'Rourke P R, Colan S D, Geha R S, Crone R. Cardiotoxicity during treatment of severe childhood asthma. Pediatrics 1991; 88: 1180
- Guidelines for the Diagnosis and Management of Asthma. U.S. Department of Health and Human Services Publication No 91–3042, August, 1991, National Asthma Education Program Expert Panel Report.
- Lemanske R F, Jr, Joad J P. Uses of β2-agonists in asthma: A comparison. J Asthma 1990; 27: 101
- Spitzer W O, Suissa S, Ernst P, et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501
- Ernst P, Habbick B, Sussa S, et al. Is the association between inhaled beta-agonist use and life threatening asthma because of confounding by severity?. Am Rev Respir Dis 1993; 148: 75
- Newth C J, Amsler B, Anderson G P, Morley J. The ventilatory and oxygen costs in the anesthetized rhesus monkey of inhaling drugs used in the therapy and diagnosis of asthma. Am Rev Respir Dis 1991; 143: 776
- Nicklas R A, Whitehurst V E, Donohoe R F, Balacz T. Concomitant use of beta adrenergic agonists and methylxanthines. J Allergy Clin Immunol 1984; 73: 796
- Rossing T H, Fanta C H, Goldstein D H, Snapper J R, McFadden E R, Jr, The Medical House Staff of the Peter Bent Brigham Hospital. Emergency therapy of asthma: Comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis 1980; 122: 365
- Josephson G W, Mackenzie E J, Lietman P S, Gibson G. Emergency treatment of asthma. A comparison of two treatment regimens. JAMA 1979; 242: 639
- Fanta C, Rossing T H, McFadden E R, Jr. Emergency room treatment of asthma. Relationships among therapeutic combinations, severity of obstruction and time course of response. Am J Med 1982; 72: 416
- Siegel D, Sheppard, Gleb A, Weinberg P F. Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. Am Rev Respir Dis 1985; 132: 283
- Peters M J, Adcock I M, Brown C R, Barnes P J. β-agonist inhibition of steroid receptor CNA binding activity in human lung. Am Rev Respir Dis 1993; 147: A772, (abstract)
- Sears M R, Taylor D R, Print C G, Lake D C, Li Q Q, Flannery E M. Regular inhaled β-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391